Back to applicants
HR

Harper R.

Enrolled Possible 64/100 Meta Applied Aug 16
Email Call Text
AI pre-screen Possible 64/100

Meets the core inclusion criteria; a couple of items to confirm at the screening visit.

Screening detail
Meets criteria
Age within the protocol range
Reported diagnosis of Acute Migraine aligns with inclusion
No exclusionary condition reported on the screener
To confirm
Confirm migraine onset before age 50
Rule out medication-overuse headache
Step 2 · Message Harper

Write them from the thread on this page. We do not email applicants a calendar or ask them to pick a time.

AI-assisted decision support. A qualified team member must review and decide.
Messages
Applied Aug 16 · via Meta
Your screening visit is booked for 2026-08-16 11:00 at Northwind Clinical Research. We'll remind you beforehand.
Hi Harper, thanks for applying - you look like a strong fit. Any questions before we book your screening visit?
I've attached my insurance card and the signed consent form.
Enter to send · Shift+Enter for a new line
Contact & details
Applied to
Elismetrep (K-304) Long-Term Safety in Acute Migraine
NCT07674654

Stage advances from what you do. Accepting marks them likely eligible; booking a visit moves them to screening.

Patient portal

Give Harper R. a private page to follow their own status, see what's outstanding, and message you back , no account signup. The link and a one-time password are sent straight to their message thread.

Notes team-only

Type @ to pull a teammate into this thread instead of CC-ing them on an email.

No notes yet. Jot context only your team sees.
Tasks
No to-dos yet.
Screening answers
Can travel to the study site Yes
Currently in another trial No
Pregnant / planning pregnancy No
Can give own consent Yes
Documents
No documents shared.
Timeline
application received
2026-07-17 06:34 · you
ready for study-team review
2026-07-17 06:34 · you
accepted - likely eligible
2026-08-14 06:34 · you
invited to screening visit
2026-08-15 06:34 · site
enrolled in study
2026-08-16 06:34 · site